Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FOREX-Dollar firms as U.S. yields march on ahead of Fed guidance

Wed, 17th Mar 2021 12:19

* U.S. 10-year yields jump to 13 month high
* Fed 2023 rates projections under scrutiny
* Euro may be hampered by delay in vaccine rollouts
* Rouble falls after Biden Putin will pay for election
interference
* Graphic: World FX rates https://tmsnrt.rs/2RBWI5E

(Adds comments, rouble falling on Biden, updates prices)
By Julien Ponthus
LONDON, March 17 (Reuters) - The U.S. dollar firmed on
Wednesday with 10-year Treasury yields hitting fresh 13-month
highs ahead of a Federal Reserve policy meeting which could shed
some light on the timing of future rate hikes and the central
bank’s tolerance for rising yields.
With Fed policymakers expected to forecast the fastest U.S.
economic growth in decades in the wake of COVID-19 vaccinations
and $1.9 trillion in new stimulus, market participants will be
focused on clues that the central bank could start raising rates
in 2023, earlier than it had said.
In any event, expectations of a faster-than-expected
economic recovery will likely weigh.
"U.S. yields might receive further upwards thrust and pull
the dollar along with them in the absence of a clear commitment
on the part of the Fed that a further rise in yields is
undesirable", Commerzbank analyst Antje Praefcke wrote in a
morning note.
She added that because the European Central Bank had in
contrast committed to increasing the pace of bond buying to keep
a lid on rising yields, the euro might suffer against the dollar
in the short term.
By midday in Europe, Benchmark 10-year Treasury yields
had crossed the 1.67% bar, their highest level since
February 2020.
The euro was down 0.05% at $1.1896 after declining in
the past three sessions.
Hurt by a possible delay in the European Union's vaccination
effort, the euro seemed set to test last week's 3 1/2-month low
of $1.1835.
Europe's medicines watchdog will release results of its
investigation into incidents of bleeding, blood clots and low
platelet counts in recipients of AstraZeneca's
coronavirus vaccine on Thursday afternoon.
"There is a risk that public trust on the vaccine has been
compromised, and this may weigh on the euro as the vaccination
gap between the EU and US may widen even further," ING analysts
warned.
Europe's painful recovery from the pandemic is in sharp
contrast with other economies, which seem less dependent on
monetary stimulus to pull though.
The Bank of Canada for instance is likely to reduce its bond
purchases as soon as next month, strategists say.
At 1155 GMT, the dollar index was up 0.09% and stood at
91.952, having already risen for three straight sessions
on support mainly from elevated U.S. bond yields.
The rouble fell 1.5% against the dollar to 73.78
after U.S. President Joe Biden said Russian
President Vladimir Putin would face consequences for directing
efforts to swing the 2020 U.S. presidential election to Donald
Trump.
"They're will be more sanctions coming, that is clear, the
question is how severe," said North Asset Management fund
manager Peter Kisler.
Against the yen, the greenback firmed 0.18% to 109.19 yen
, hovering near nine-month highs hit this week.
The British pound was up 0.04% at $1.3901 recovering
from profit-taking after it hit a near three-year high last
month on the back of a fast vaccine roll-out.
Commodity-linked currencies including the Australian dollar
, the New Zealand dollar and the Canadian dollar
traded lower against the U.S. dollar.
In the cryptocurrency market, bitcoin fell 3.6%
to $54,870.00, slipping further away from a record high of
$61,781.83 hit on Saturday.

========================================================
Currency bid prices at 1200 GMT
Description RIC Last U.S. Close Pct Change YTD Pct High Bid Low Bid
Previous Change
Session
Euro/Dollar $1.1892 $1.1903 -0.09% -2.67% +1.1917 +1.1887
Dollar/Yen 109.1850 109.0200 +0.15% +5.71% +109.2250 +109.0650
Euro/Yen 129.85 129.75 +0.08% +2.31% +130.0000 +129.7200
Dollar/Swiss 0.9285 0.9248 +0.38% +4.93% +0.9285 +0.9248
Sterling/Dollar 1.3896 1.3895 +0.01% +1.72% +1.3929 +1.3880
Dollar/Canadian 1.2470 1.2448 +0.18% -2.07% +1.2476 +1.2434
Aussie/Dollar 0.7713 0.7746 -0.42% +0.27% +0.7747 +0.7713
NZ Dollar/Dollar 0.7165 0.7190 -0.33% -0.21% +0.7194 +0.7166


All spots
Tokyo spots
Europe spots
Volatilities
Tokyo Forex market info from BOJ


(Reporting by Julien Ponthus and Marc Jones in London; Editing
by Sam Holmes, Gerry Doyle, Andrew Cawthorne and Giles Elgood)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.